Artesunate + amodiaquine versus artemether-lumefantrine for the treatment of uncomplicated plasmodium falciparum malaria in the colombian pacific region: A noninferiority trial;Artesunato + amodiaquina versus artemether-limefantrina para o tratamento da malaria não complicada por plamodium falciparum no pacifico colombiano: Um estudo de não inferioridade

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 45, Issue 6, 2012, Pages 732-738

  De la Hoz Restrepo, Fernando ^a   Ramírez, Alexandra Porras ^a   Mendoza, Alejandro Rico ^a   Córdoba, Freddy ^b   Rojas, Diana Patricia ^c  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^b Health Administrative Department (Dasalud)   (Colombia)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Artemether lumefantrine combination; Artesunate amodiaquine combination; Colombia; Efficacy; Malaria falciparum; Safety

Indexed keywords

AMODIAQUINE PLUS ARTESUNATE; ARTEMETHER PLUS BENFLUMETOL; COARSUCAM; PRIMAQUINE; QUININE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; ARTICLE; COLOMBIA; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; EPIGASTRIC BURNING; FEMALE; FEVER; GENE; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MSP1 GENE; MULTICENTER STUDY; OPEN STUDY; PARASITE CLEARANCE; PARASITEMIA; POLYMERASE CHAIN REACTION; RANDOMIZED CONTROLLED TRIAL;

ADULT; AMODIAQUINE; ANTIMALARIALS; ARTEMISININS; COLOMBIA; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; ETHANOLAMINES; FEMALE; FLUORENES; HUMANS; MALARIA, FALCIPARUM; MALE; TREATMENT OUTCOME;

ARTESUNATE; PLASMODIUM FALCIPARUM;

EID: 84872313851     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822012000600015     Document Type: Article

References (35)

1. World Helath Organization Global Malaria Programme. WHO Malaria Report: 2010. Geneva: WHO Press; 2011.
2. Moyano M, Mendez F. Erythrocyte defects and parasitemia density in patients with Plasmodium falciparum malaria in Buenaventura, Colombia [in Spanish].Rev Panam Salud Publica 2005; 18:25-32.
3. Rodríguez JC, Uribe GÁ, Araújo RM, Narváez PC, Valencia SH. Epidemiology and control of malaria in Colombia. Mem Inst Oswaldo Cruz 2011; 106 (supl I):114-122.
4. Censo General 2005. Nivel Nacional [in Spanish]. Bogotá, Colombia: Departamento Administrativo Nacional de Estadística, 2005.
5. Ochoa J, Osorio L. Epidemiology of urban malaria in Quibdó, Chocó [in Spanish]. Biomedica 2006; 26:278-285.
6. Valero-Bernal MV. Malaria in Colombia: retrospective glance during the past 40 years. Rev Salud Publica (Bogotá) 2006; 8:141-149.
7. Bray PG, Ward SA, O'Neill PM. Quinolones and artemisinin: chemistry, biology and history. In: Sullivan DJ, Krishna S, editors. Malaria: drugs, disease and post-genomic biology. Berlin, Germany: Springer-Verlag; 2005. p. 3-98.
8. González IJ, Varela RE, Murillo C, Ferro BE, Salas J, Giraldo LE, et al. Polymorphisms in cg2 and pfcrt genes and resistance to chloroquine and other antimalarials in vitro in Plasmodium falciparum isolates from Colombia. Trans R Soc Trop Med Hyg 2003; 97:318-324.
9. Samudio F, Santamaria AM, Obaldia III N, Pascale JM, Bayard V, Calzada JE. Prevalence of Plasmodium falciparum mutations associated with antimalarial drug resistance during an epidemic in Kuna Yala, Panama, Central America. Am J Trop Med Hyg 2005; 73:839-841.
10. Leal O, Leal EA, Borges Júnior FR, Paez ML, Teodosio S, Tavares-Neto J. Clinical-parasitological response to treatment with quinine associated to doxycycline in uncomplicated falciparum malaria [in Portuguese]. Rev Soc Bras Med Trop 2003; 36:751-754.
11. World Health Organization. Guidelines for the Treatment of Malaria. Geneva: WHO Press; 2006.
12. Alker AP, Lim P, Sem R, Shah NK, Yi P, Bouth DM, et al. Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border. Am J Trop Med Hyg 2007; 76:641-647.
13. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009; 361:455-467.
14. Zwang J, Olliaro P, Barennes H, Bonnet M, Brasseur P, Bukirwa H, et al. Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis. Malar J 2009; 8:203.
15. Conteh L, Sicuri E, Manzi F, Hutton G, Obonyo B, Tediosi F, et al. The cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan Africa. PLoS One 2010; 5:e10313.
16. Osorio L, Gonzalez I, Olliaro P, Taylor WR. Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia. Malar J 2007; 6:25.
17. World Health Organization. Methods for Surveillance of Antimalarial Drug Efficacy. France: WHO Press; 2009.
18. Amazon Network for the Surveillance of Antimalarial Drug Resistance. Amazon Malaria Initiative (RAVEDRA-AMI). Practical Guide for in vivo Antimalarial Drug-Efficacy Studies in the Americas. PAHO Publication OPS/DPC/CD/240/03. [Cited 2011 January 8]. Available from: http://www.paho.org/english/ad/dpc/cd/guia-practica.pdf.
19. Center for Drug Evaluation and Research; Food and Drug Administration. Guidance for Industry. Malaria: Developing Drug and Nonvaccine Biological Products for Treatment and Prophylaxis. Rockville, MD: U.S. Department of Health and Human Services; 2007. [Cited 2011 January 8]. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071951.pdf.
20. Dasgupta A, Lawson KA, Wilson JP. Evaluating equivalence and noninferiority trials. Am J Health Syst Pharm 2010; 67:1337-1343.
21. Stepniewska K, White NJ. Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria. Malar J 2006; 5:127.
22. World Medical Association. WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. 2008. Seoul, Korea, World Medical Association. [Cited 2011 January 8]. Available from: http://www.wma.net/en/30publications/10policies/b3/index.html.
23. Sinclair D, Zani B, Donegan S, Olliaro P, Garner P. Artemisinin-based combination therapy for treating uncomplicated malaria. Cochrane Database Syst Rev 2009; CD007483.
24. Taylor-Robinson D, Jones K, Garner P. Malaria: uncomplicated, caused by Plasmodium falciparum. Clin Evid 2007; [Cited 2011 August 8]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2907983/?tool=pubmed/.
25. Jansen FH, Lesaffre E, Penali LK, Zattera MJ, Die-Kakou H, Bissagnene E. Assessment of the relative advantage of various artesunate-based combination therapies by a multi-treatment Bayesian random-effects meta-analysis. Am J Trop Med Hyg 2007; 77:1005-1009.
26. Balint GA. Artemisinin and its derivatives: an important new class of antimalarial agents. Pharmacol Ther 2001; 90:261-265.
27. Ferreira MU. The merozoite surface protein-1 (MSP-1) of Plasmodium falciparum: allelic diversity and immune recognition [abstract]. Rev Soc Bras Med Trop 1998; 31:395-397.
28. Pereira FJ, Cordeiro JA, Hoffmann EH, Ferreira MU. Genetic diversity and differentiation in natural Plasmodium falciparum populations inferred by molecular typing of the merozoite surface proteins 1 and 2. Rev Soc Bras Med Trop 2002; 35:527-530.
29. Barrera SM, Pérez MA, Knudson A, Nicholls RS, Guerra AP. Genotypic survery of Plasmodium falciparum based on the msp1, msp2 and glurp genes by multiplex PCR [in Spanish]. Biomedica 2010; 30:530-538.
30. Guerra AP, Knudson A, Nicholls RS, Galindo JA, Ravid Z, Rahirant S, et al. Genotyping of the Plasmodium falciparum msp1 (block 2) and dhfr (codon 108) genes in field samples collected in four endemic Colombian localities [in Spanish]. Biomedica 2006; 26:101-112.
31. Montoya L, Maestre A, Carmona J, Lopes D, Rosário V, Blair S. Plasmodium falciparum: diversity studies of isolates from two Colombian regions with different endemicity. Exp Parasitol 2003;104:14-19.
32. Koram KA, Abuaku B, Duah N, Quashie N. Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana. Acta Trop 2005; 95:194-203.
33. White NJ. The assessment of antimalarial drug efficacy. Trends Parasitol 2002; 18:458-464.
34. World Health Organization. Global report on antimalarial drug efficacy and drug resistance: 2000-2010. Geneva, Switzerland: WHO Press; 2010.
35. Asante KP, Owusu R, Dosoo D, Awini E, Adjei G, Amenga Etego S, et al. Adherence to artesunate-amodiaquine therapy for uncomplicated malaria in rural Ghana: a randomised trial of supervised versus unsupervised drug administration. J Trop Med 2009; 2009:529-583.